Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C
Clicks: 206
ID: 7601
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
80.3
/100
206 views
165 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C| Reference Key |
childskean2019profileinfection
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lindsey M Childs-Kean;Natalie A Brumwell;Emma F Lodl; |
| Journal | Infection and drug resistance |
| Year | 2019 |
| DOI | 10.2147/IDR.S171338 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.